SPP1 and neoplasm: Additionally, we observed a positive trend in the relationship between SPP1 expression and the tumor’s response to EURONET-PHL-C2 treatment, a phase II treatment focused on adapting treatment strategies to minimize the use of radiotherapy in an effort to lower potential late toxicity experienced in patients during the follow-up period [6].